Cargando…
Erratum to: Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells
Autores principales: | Skolekova, Svetlana, Matuskova, Miroslava, Bohac, Martin, Toro, Lenka, Durinikova, Erika, Tyciakova, Silvia, Demkova, Lucia, Gursky, Jan, Kucerova, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768410/ https://www.ncbi.nlm.nih.gov/pubmed/26915660 http://dx.doi.org/10.1186/s12964-016-0130-5 |
Ejemplares similares
-
Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells
por: Skolekova, Svetlana, et al.
Publicado: (2016) -
Altered features and increased chemosensitivity of human breast cancer cells mediated by adipose tissue-derived mesenchymal stromal cells
por: Kucerova, Lucia, et al.
Publicado: (2013) -
Tyrosine kinase inhibitor SU11274 increased tumorigenicity and enriched for melanoma-initiating cells by bioenergetic modulation
por: Kucerova, Lucia, et al.
Publicado: (2016) -
Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases
por: Matuskova, Miroslava, et al.
Publicado: (2015) -
Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells
por: Schmidtova, Silvia, et al.
Publicado: (2019)